Non-Invasive Prenatal Testing Market Projected to Grow at a CAGR of 13.02% to Reach USD 12.20 Billion by 2031

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Non-Invasive Prenatal Testing Market By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA In Maternal Plasma Tests And Others), End-User (Diagnostic Laboratories, Hospitals, Research Centres And Clinics.), Application (Trisomy, Microdelection Syndrome And Others)- Trends, Industry Competition Analysis, Revenue And Forecast To 2031."

The global non-invasive prenatal testing market is estimated to reach over USD USD 12.20 billion by the year 2031, exhibiting a CAGR of 13.02% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1425

Non-invasive prenatal testing (NIPT), also referred to as non-invasive prenatal screening, is a method employed to assess the likelihood of genetic disorders in a fetus. This technique is highly accurate and presents no risk to either the mother or the fetus. It is primarily used for detecting chromosomal abnormalities, including Down syndrome, Patau syndrome, Edwards syndrome, and Turner syndrome. The process involves analyzing small fragments of fetal DNA that circulate in the maternal bloodstream, which can be detected as early as the 10th week of pregnancy.

The market for non-invasive prenatal testing is experiencing substantial growth, largely driven by the increasing incidence of chromosomal abnormalities and the rising maternal age. The likelihood of genetic disorders rises with maternal age, particularly in pregnancies over the age of 35. As a result, obstetricians are progressively recommending NIPT as a proactive measure to ensure healthier pregnancies, thereby fueling market expansion.

Additionally, technological advancements are improving the cost-effectiveness of NIPT, which is expected to further stimulate market growth in the coming years. Increased research and development (R&D) activities focused on creating innovative testing solutions are anticipated to drive further market expansion. Moreover, growing government investment in R&D for non-invasive prenatal testing is expected to provide a favorable environment for continued market growth.

List of Prominent Players in the Non-Invasive Prenatal Testing Market:
Yourgene Health
Illumina Inc.
Agilent Technologies Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Laboratory Corporation of America Holdings
GE Healthcare
PerkinElmer Inc.
BGI
Natera Inc.

Market Dynamics:
Drivers-
The development of advanced screening techniques with improved sensitivity and accuracy for the early detection of genetic abnormalities in newborns remains a central objective for many companies. Manufacturers are concentrating on the advancement of innovative non-invasive prenatal diagnostic solutions while strategically engaging in partnerships and collaborations to enhance their competitive position in the market. Furthermore, the adoption of non-invasive prenatal testing is projected to increase over the forecast period, driven by supportive reimbursement policies and heightened awareness of the advantages of non-invasive methods over traditional invasive prenatal diagnostics.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges
The widespread adoption of non-invasive prenatal testing (NIPT) is anticipated to be hindered by its high cost, which makes it unaffordable in many developing countries. For example, in India, the average cost of NIPT ranges from USD 350 to USD 400, limiting its accessibility in emerging markets. Additionally, a general lack of awareness regarding the risks of genetic disorders in these regions further constrains market growth. Other factors, such as low per capita healthcare spending and inadequate reimbursement policies for NIPT, are expected to pose additional challenges to the global expansion of the market.

Regional Trends
The North American non-invasive prenatal testing market is projected to capture a significant share of the global market in terms of revenue, with robust growth expected in the near term. This growth is driven by the rising prevalence of genetic disorders at birth, an increasing demand for advanced screening methods, and expanding reimbursement coverage for pregnancy-related risks. According to research from the Health Expense Institute, the North American NIPT market is poised to benefit from an average annual healthcare expenditure of USD 4,879.0 per child in the United States. Moreover, major market players' strategic focus on broadening their product portfolios is expected to further propel market expansion and increase demand for NIPT.

The Asia Pacific non-invasive prenatal testing market has also experienced substantial growth, supported by the rising incidence of chromosomal aneuploidies in newborns and increasing maternal age, which has expanded the potential customer base. The integration of next-generation sequencing (NGS) technologies, significant advancements in China and Japan, and improvements in regional healthcare infrastructure are expected to contribute to the continued expansion of the market in this region.

Recent Developments:
• In July 2021, Pacific Biosciences and Omniome, a San Diego-based business, inked a binding merger agreement. This partnership will increase sequencing opportunities and benefit customers through creative market expansion strategies.
• In June 2021, VeriSeq NIPT Solution v2 was introduced in Thailand by Illumina, Inc. and Next-Generation Genomic Co., Ltd. End-to-end genome-wide non-invasive prenatal testing is available with VeriSeq NIPT Solution and is accurate, dependable, scalable, and quick.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1425

Segmentation of Non-Invasive Prenatal Testing Market-
By Method-
• Ultrasound Detection
• Biochemical Screening Tests
• Cell-free DNA in Maternal Plasma Test
• Others
By End-Use-
• Diagnostic Laboratories
• Hospitals
• Research Centers
• Clinics
By Application-
• Trisomy
• Microdelection Syndrome
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/non-invasive-prenatal-testing-market/1425

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.